Not sure the relevance of that article with Allogene being granted Fast Track end of last month for their cancer therapy ? - maybe the “shares increase” bit ? … yet they’ve been trending down and now 15% lower since ?
Fast Track is helpful over time with the bigger picture but there’s no instant gratification - it’s all about how the prospective drugs deliver with clinical trials into the future.
Not sure the relevance of that article with Allogene being...
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
